AIHTA - Publications - Search - Odronextamab (Ordspono®) as monotherapy for the treatment of relapsed or refractory follicular lymphoma (r/r FL) or diffuse large B‑cell lymphoma (r/r DLBCL)

Rothschedl, E. and Grössmann, N. (2024): Odronextamab (Ordspono®) as monotherapy for the treatment of relapsed or refractory follicular lymphoma (r/r FL) or diffuse large B‑cell lymphoma (r/r DLBCL). Fact Sheet Nr. 181.

[thumbnail of Fact Sheet Nr.181.pdf]
Preview
 PDF - Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. GSview, Xpdf oder Adobe Acrobat Reader
388kB

Item Type:Horizon Scanning of Medicines
Subjects:QV Pharmacology, toxicology, pharmacy > QV 60-370 Pharmacology
QZ Pathology > QZ 200-380 Neoplasms.Cysts
WB Practice of medicine > WB 300-962 Therapeutics
WH Hemic and lymphatic systems
Language:English
Series Name:Fact Sheet Nr. 181
Deposited on:07 Aug 2024 11:32
Last Modified:10 Jul 2025 11:38

Repository Staff Only: item control page